Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory myeloma
Titel:
Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory myeloma
Auteur:
Shah, Jatin J. Stadtmauer, Edward A. Abonour, Rafat Cohen, Adam D. Bensinger, William I. Gasparetto, Cristina Kaufman, Jonathan L. Lentzsch, Suzanne Vogl, Dan T. Gomes, Christina L. Pascucci, Natalia Smith, David D. Orlowski, Robert Z. Durie, BrianG.M.